Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Eli Lilly and United Therapeutics extend licence agreement
Americas
Pharmaceutical company United Therapeutics and Eli Lilly have extended and amended a nearly decade-long licence agreement covering Adcirca.   23 May 2017
AstraZeneca sells beta-blocker commercial rights for $300m
Big Pharma
Pharmaceutical company Recordati has paid AstraZeneca $300 million for the European commercial rights to beta-blockers.   22 May 2017
Americas
AbbVie has lost in an inter partes review (IPR) of its rheumatoid arthritis drug Humira.   19 May 2017
Americas
Eli Lilly has been ordered by a district court to pay Germany-based company Erfindergemeinschaft UroPep $20 million for patent infringement.   19 May 2017
Americas
McNair Law Firm has expanded its IP practice with the addition of John Johnson as a shareholder in the firm.   19 May 2017
article
Medical technology companies should not be left out of discussions in Europe about modernising the system for supplementary protection certificates, argues Allison Sadick of Pinsent Masons.   19 May 2017
Americas
Medical device company ResMed has filed a motion to dismiss its International Trade Commission (ITC) complaint against New Zealand-based Fisher & Paykel.   18 May 2017
Americas
Merck and Upsher-Smith Laboratories have agreed to pay $60.2 million in settlement fees to direct drug purchasers.   18 May 2017
Big Pharma
The European Commission has opened an investigation into multinational company Aspen Pharma over the price of five cancer drugs.   17 May 2017
Americas
A California-based man has pleaded guilty to manufacturing counterfeit veterinary product labels.   17 May 2017